Figure 1
JAK/STAT pathway analysis in A) monocytes from MPD patient samples and in B) circulating CD34+ cells in the presence/absence of JAK2 inhibitors
JAK/STAT pathway analysis in A) monocytes from MPD patient samples and in B) circulating CD34+ cells in the presence/absence of JAK2 inhibitors
